Caribou Biosciences (CRBU) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Voting matters and shareholder proposals
Election of three Class II directors to serve until the 2029 annual meeting, with nominees Andrew Guggenhime, David Johnson, and Nancy Whiting recommended for election.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Approval sought for an amendment to the certificate of incorporation to provide for officer exculpation from certain fiduciary duty breaches as permitted by Delaware law.
Proposal to approve adjournment of the annual meeting if necessary to solicit additional votes or establish a quorum.
Proxies authorized to vote on any other business that may properly come before the meeting or any adjournments.
Board of directors and corporate governance
Board recommends all three director nominees for election to serve five-year terms.
Audit committee and external auditor matters
Deloitte & Touche LLP recommended for ratification as the external auditor for the upcoming fiscal year.
Latest events from Caribou Biosciences
- Key votes include director elections, auditor ratification, and officer exculpation amendment.CRBU
Proxy filing5 Jun 2026 - Pivotal-ready and phase I CAR T programs advance, with major data updates expected at EHA.CRBU
Jefferies Global Healthcare Conference 20264 Jun 2026 - Allogeneic CAR T programs show strong clinical progress and are advancing toward pivotal trials.CRBU
H.C. Wainwright 4th Annual BioConnect Investor Conference19 May 2026 - Off-the-shelf CAR-T therapies show strong clinical promise and scalable commercial potential.CRBU
Bank of America Global Healthcare Conference 202613 May 2026 - Net loss narrowed to $25.2M, cash of $118.6M may fund operations into 2H 2027.CRBU
Q1 20267 May 2026 - Key proposals include director elections, auditor ratification, and officer exculpation.CRBU
Proxy filing1 May 2026 - 2026 meeting covers director elections, auditor ratification, and officer exculpation proposals.CRBU
Proxy filing24 Apr 2026 - 2026 meeting covers director elections, auditor ratification, and officer exculpation amendment.CRBU
Proxy filing10 Apr 2026 - Pivotal trial planning advances for vispa-cel, with global commercialization and funding strategies outlined.CRBU
Leerink Global Healthcare Conference 202610 Mar 2026